Literature DB >> 7627320

Combined electroneurographic and electromyographic studies in lead workers.

J H Yeh1, Y C Chang, J D Wang.   

Abstract

OBJECTIVES: To evaluate the effects of chronic exposure to lead on the peripheral nervous system in lead workers.
METHODS: Nerve conduction velocity and electromyographic studies were performed on 31 lead workers of a battery recycling factory and 31 sex and age matched controls. 25 cases with mild distal extensor weakness of the upper limbs were classified as the lead neuropathy subgroup and the rest of the lead workers as the lead exposure subgroup. Blood lead concentrations and haematological and biochemical data were recorded. An index of cumulative exposure to lead was calculated by the summation of multiplying the average blood concentration of lead with the duration of exposure at various jobs.
RESULTS: Compared with the control group, the distal motor latency of the median nerve was significantly prolonged in the lead neuropathy subgroup, but not in the exposure subgroup. Only six of 31 workers had nerve conduction abnormalities, whereas electromyographic evidence of denervation was found in 93.5% of the lead neuropathy subgroup and 83.5% in the lead exposure subgroup. The electromyographic abnormalities found were neurogenic polyphasic waves in all 29 workers with abnormal electromyographic findings (grade in seven cases and grade ++ in the rest). Spontaneous activity was only recorded in seven workers, with grade + in four and grade ++ in three. There was a positive linear correlation between the index of cumulative exposure to lead and the distal motor latencies of the tibial nerve as well as a negative correlation with conduction velocities of the sural nerve after multivariate analysis and control of potential confounding by age and sex. No correlation could be found between the electrophysiological values and a simple duration of exposure or concentration of blood lead. A non-parametric analysis showed that there was a trend of higher index of cumulative exposure to lead with more severe electromyographic changes. Electromyographic abnormality also occurred in workers with blood lead concentrations between 17.4 and 58 micrograms/dl.
CONCLUSION: Electromyographic study in the distal extensors of the upper limbs may be used as a tool for biological monitoring of effect in lead workers.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7627320      PMCID: PMC1128247          DOI: 10.1136/oem.52.6.415

Source DB:  PubMed          Journal:  Occup Environ Med        ISSN: 1351-0711            Impact factor:   4.402


  22 in total

1.  RESPONSE TO TREATMENT WITH CHELATING AGENTS OF ANAEMIA, CHRONIC ENCEPHALOPATHY, AND MYELOPATHY DUE TO LEAD POISONING.

Authors:  J A SIMPSON; D A SEATON; J F ADAMS
Journal:  J Neurol Neurosurg Psychiatry       Date:  1964-12       Impact factor: 10.154

2.  Electrophysiology and nerve biopsy in men exposed to lead.

Authors:  F Buchthal; F Behse
Journal:  Br J Ind Med       Date:  1979-05

3.  Subclinical neuropathy at "safe" levels of lead exposure.

Authors:  A M Seppäläinen; S Tola; S Hernberg; B Kock
Journal:  Arch Environ Health       Date:  1975-04

4.  Lead neuropathy in adults and children.

Authors:  R G Feldman; M K Hayes; R Younes; F D Aldrich
Journal:  Arch Neurol       Date:  1977-08

5.  Subclinical effects of chronic increased lead absorption--a prospective study. II. Results of baseline neurologic testing.

Authors:  R W Baloh; G H Spivey; C P Brown; D Morgan; D S Campion; B L Browdy; J L Valentine; H C Gonick; F J Massey; B D Culver
Journal:  J Occup Med       Date:  1979-07

6.  Subclinical neuropathy in lead workers.

Authors:  M J Catton; M J Harrison; P M Fullerton; G Kazantzis
Journal:  Br Med J       Date:  1970-04-11

7.  Reversible forms of motor neuron disease. Lead "neuritis".

Authors:  J A Boothby; P V DeJesus; L P Rowland
Journal:  Arch Neurol       Date:  1974-07

8.  Absence of peripheral neuropathy in long-term lead-exposed subjects.

Authors:  C J Nielsen; V K Nielsen; H Kirkby; F Gyntelberg
Journal:  Acta Neurol Scand       Date:  1982-04       Impact factor: 3.209

9.  Subclinical effects of chronic increased lead absorption--a prospective study. III. Neurologic findings at follow-up examination.

Authors:  G H Spivey; R W Baloh; C P Brown; B L Browdy; D S Campion; J L Valentine; D E Morgan; B D Culver
Journal:  J Occup Med       Date:  1980-09

10.  A neurological and biochemical study of early lead poisoning.

Authors:  J A Ashby
Journal:  Br J Ind Med       Date:  1980-05
View more
  6 in total

1.  Effect of exposure to lead on postural control in workers.

Authors:  N Ratzon; P Froom; E Leikin; E Kristal-Boneh; J Ribak
Journal:  Occup Environ Med       Date:  2000-03       Impact factor: 4.402

2.  Vibration perception thresholds in workers with long term exposure to lead.

Authors:  H Y Chuang; J Schwartz; S Y Tsai; M L Lee; J D Wang; H Hu
Journal:  Occup Environ Med       Date:  2000-09       Impact factor: 4.402

3.  Effects of low level exposure to lead on neurophysiological functions among lead battery workers.

Authors:  T Kovala; E Matikainen; T Mannelin; J Erkkilä; V Riihimäki; H Hänninen; A Aitio
Journal:  Occup Environ Med       Date:  1997-07       Impact factor: 4.402

4.  Associations between bone mineral density, grip strength, and lead body burden in older men.

Authors:  Naila Khalil; Kimberly A Faulkner; Susan L Greenspan; Jane A Cauley
Journal:  J Am Geriatr Soc       Date:  2014-01-02       Impact factor: 5.562

5.  Effect of lead exposure and ergonomic stressors on peripheral nerve function.

Authors:  Margit L Bleecker; D Patrick Ford; Christopher G Vaughan; Karen N Lindgren; Michael J Tiburzi; Karin Scheetz Walsh
Journal:  Environ Health Perspect       Date:  2005-12       Impact factor: 9.031

6.  Association between blood lead and walking speed in the National Health and Nutrition Examination Survey (NHANES 1999-2002).

Authors:  John S Ji; Alexis Elbaz; Marc G Weisskopf
Journal:  Environ Health Perspect       Date:  2013-04-19       Impact factor: 9.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.